Flumethasone-d3 (CAS 2135-17-3 (unlabeled))

Flumethasone-d3 is a glucocorticoid receptor agonist that functions by binding to the glucocorticoid receptor in the cytoplasm of target cells. Upon binding, the flumethasone-d3-receptor complex translocates into the nucleus, where it acts as a transcription factor, modulating the expression of various genes. This modulation leads to the suppression of pro-inflammatory genes, such as cytokines and chemokines, thereby reducing the inflammatory response. Flumethasone-d3 induces the expression of anti-inflammatory proteins, such as lipocortin-1, which further contributes to its anti-inflammatory effects. Flumethasone-d3 inhibits the activity of phospholipase A2, an enzyme involved in the production of inflammatory mediators, such as prostaglandins and leukotrienes. By interfering with these cellular processes, flumethasone-d3 effectively dampens the immune response and reduces inflammation. The molecular interactions of flumethasone-d3 play a role in its anti-inflammatory mechanism of action.